Awake Intubation V-MAC VS

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Completed
CT.gov ID
NCT03742830
Collaborator
(none)
36
1
7.8
4.6

Study Details

Study Description

Brief Summary

Nowadays, the gold standard for difficult airway management is awake intubation with a flexible fiberscope. Alternatively, when the flexible fiberscope is unable to facilitate tracheal intubation, rigid stylets may be used. One newly developed rigid video stylet also features a flexible tip (C-MAC VS, Karl Storz AG, 78532 Tuttlingen, Germany). The distal angular offset of the C-MAC VS, in which the camera and light sources are integrated, can be aligned (up to 60°) to the patient's anatomical structures to facilitate intubation.

Although awake intubation is less comfortable for the patient and more time consuming, there are several reasons why this is often performed. The investigators plan a prospective observational with 36 participants using the C-MAC VS on adult patients with indication for awake oral intubation.

To ease the placement of the tube (intubation), the investigators will use local anesthesia of the mucosa in the mouth, pharynx and larynx.

The main purpose of the study is to prove the feasibility of successful awake intubation with the C-MAC VS in adult patients. If the new device proves reliable in facilitating awake oral, future patients benefit from an additional tool that allows fast and safe intubation in difficult airway situations.

Condition or Disease Intervention/Treatment Phase
  • Device: C-MAC VS

Detailed Description

In the majority of cases, airway management is uncomplicated and a straightforward procedure. Nevertheless, in rare cases complications are associated with notably high rates of serious consequences.

Therefore, assured and reliable intubation is fundamental to safe anesthetic practice.

Various approaches were introduced by the medical device industry to optimize intubation procedure. Nowadays, the gold standard for difficult airway management is awake intubation with a flexible fiberscope. Alternatively, when the flexible fiberscope is unable to facilitate tracheal intubation, rigid stylets may be used. One newly developed rigid video stylet also features a flexible tip (C-MAC VS, Karl Storz AG, 78532 Tuttlingen, Germany). The C-MAC VS is an advancement of the rigid "Bonfils" stylet (Karl Storz, Karl Storz AG, 78532 Tuttlingen, Germany). The distal angular offset of the C-MAC VS, in which the camera and light source are integrated, can be aligned (up to 60°) to the patient's anatomical structures to facilitate intubation.

Although awake intubation is less comfortable for the patient and more time consuming, there are several reasons why this is often performed.

In this research project, the investigators plan a prospective observational study using the C-MAC VS on adult patients with indication for awake oral intubation. Spontaneous ventilation will be maintained until confirmation of tracheal intubation.To ease the placement of the tube (intubation), the investigators will use local anesthesia of the mucosa in the mouth, pharynx and larynx.

The study physician will intubate the trachea of the patient using the C-MAC VS. Another person of the study team will record the primary and secondary outcomes on the Case Report Form.

After intubation, the anesthetist evaluates the intubation. Participants will be followed up for procedure related complications after the intubation and on the 1st post-anesthesia day to evaluate patient intubation comfort (VAS 1: very easy to 10: very hard).

The main purpose of the study is to prove the feasibility of successful awake intubation with the C-MAC VS in adult patients. If the new device proves reliable in facilitating awake oral, future patients benefit from an additional tool that allows fast and safe intubation in difficult airway situations.

Study Design

Study Type:
Observational
Actual Enrollment :
36 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Awake Intubation in Difficult Airway- a Prospective Observational Study
Actual Study Start Date :
Feb 6, 2019
Actual Primary Completion Date :
Sep 30, 2019
Actual Study Completion Date :
Sep 30, 2019

Outcome Measures

Primary Outcome Measures

  1. Intubation success [120 seconds]

    The intubation success rate at first attempt in less than 120 seconds

Secondary Outcome Measures

  1. Airway- and intubation data [Device passes patients lips until the device is completely removed out of the tracheal tube and the first end tidal CO2 is shown (the entire process should not pass 120 seconds)]

    Interim times of airway management (intubation start, first view of vocal cords, device out of the tube - first end tidal CO2)

  2. Duration of the airway management [Device passes patients lips until the device is completely removed out of the tracheal tube and the first end tidal CO2 is shown (the entire process should not pass 120 seconds)]

    The period of time that is needed for the airway management and the respiratory security

  3. Patient's comfort during intubation [On the 1st post-procedure day]

    The investigators will evaluate their comfort during intubation on the 1st post-procedure day on a VAS (visual analogue pain scale) 1-10 (1: very easy, 10: very hard).

  4. Total number of intubation attempts [The first time the device passes patients lips until the respiratory is secured so the device is completely removed out of the tracheal tube and the first end tidal CO2 is shown.]

    The total number that is needed to secure the airway with intubation

  5. Patients demographic data such as weight [During the process of screening, up to 24 hours before the study session starts]

    The weight of each patient will be presented in kilograms

  6. Patients demographic data such as size [During the process of screening, up to 24 hours before the study session starts]

    The size of each patient will be presented in meter/centimeter

  7. Patients demographic data such as gender [During the process of screening, up to 24 hours before the study session starts]

    The gender (female or male) will be presented

  8. Patients demographic data such as BMI [During the process of screening, up to 24 hours before the study session starts]

    Weight and Height will be combined to report BMI in kg/m2

  9. Patients vital parameter such as blood pressure [Device passes patients lips until the device is completely removed out of the tracheal tube and the first end tidal CO2 is shown (the entire process should not pass 120 seconds)]

    The investigators will use the standard non-invasive monitoring of the University Hospital to measure the blood pressure (in millimeters of mercury)

  10. Patients vital parameter such as heart rate [Device passes patients lips until the device is completely removed out of the tracheal tube and the first end tidal CO2 is shown (the entire process should not pass 120 seconds)]

    The investigators will use the standard non-invasive monitoring of the University Hospital to measure the heart rate (beats per minute)

  11. Patients vital parameter such as the arterial oxygen saturation [Device passes patients lips until the device is completely removed out of the tracheal tube and the first end tidal CO2 is shown (the entire process should not pass 120 seconds)]

    The investigators will use the standard non-invasive monitoring of the University Hospital to measure the arterial oxygen saturation (SaO2 in percent)

  12. The anesthetist rates the patients airway [Device passes patients lips until the device is completely removed out of the tracheal tube and the first end tidal CO2 is shown (the entire process should not pass 120 seconds)]

    The anesthetist rates the POGO (Percentage of Glottis Opening), the quality of the vision device and the intubation difficulty on a VAS (visual analogue pain scale) 1-10 (1: very easy, 10: very hard).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • indication for awake oral intubation

  • elective surgery

  • age 18-80

  • written Informed Consent

  • knowledge of the German language enough to understand the Informed Consent

Exclusion Criteria:
  • emergency patients

  • uncooperative patients

  • ASA (= Physical Status Classification System) V

  • study equipment and personal not available

Contacts and Locations

Locations

Site City State Country Postal Code
1 Inselspital, Bern University Hospital Bern Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne

Investigators

  • Principal Investigator: Robert Greif, Prof.Dr.med., University Hospital of Bern, Bern, Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT03742830
Other Study ID Numbers:
  • 2018-01454
First Posted:
Nov 15, 2018
Last Update Posted:
Jan 29, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 29, 2020